189 results
Page 5 of 10
8-K
EX-10.1
n5irq2
30 Aug 19
Entry into a Material Definitive Agreement
4:19pm
8-K
EX-99.1
xnhrigs xg
26 Jul 19
AbbVie Reports Second-Quarter 2019 Financial Results
7:44am
8-K
EX-10.1
1t0776wzvhbn439185v
16 Jul 19
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.2
2oq1x6guzf
16 Jul 19
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-2.1
6ioirqva7w7qh7h0u6pn
25 Jun 19
This Announcement Is Being Made Pursuant to Rule 2.5 of the Irish Takeover Rules
5:26pm
8-K
EX-99.1
nulx0nnq0hpj7
25 Jun 19
This Announcement Is Being Made Pursuant to Rule 2.5 of the Irish Takeover Rules
5:26pm
8-K
EX-10.1
m3pe28pz7z5hmjphh
25 Jun 19
This Announcement Is Being Made Pursuant to Rule 2.5 of the Irish Takeover Rules
5:26pm
8-K
EX-99
sa3a8k
25 Apr 19
AbbVie Reports First-Quarter 2019 Financial Results
7:45am
PX14A6G
cknqn422ovk es1
1 Apr 19
Letter to shareholders
11:51am
PX14A6G
ex0yed738ptzvpj
29 Mar 19
Letter to shareholders
11:12am
8-K
EX-99.1
2h3to
25 Jan 19
AbbVie Reports Full-Year and Fourth-Quarter 2018 Financial Results
7:46am
8-K
EX-99.1
7y672b 45
17 Dec 18
AbbVie Announces Executive Leadership Changes
9:10am
8-K
EX-99.1
zvjp 0d4y3
2 Nov 18
AbbVie Reports Third-Quarter 2018 Financial Results
7:50am
424B5
rpdcwr6m4vgqh1
13 Sep 18
Prospectus supplement for primary offering
12:00am